Back to Trades
WILSON KAREN J
DirectorCIK 0001267490
Profile
- Filings
- 6
- Buy transactions
- 4
- Sell transactions
- 0
- Companies
- 3
- Active
- 2025–2026
WILSON KAREN J, Director, has filed 6 SEC reports (2025–2026), spread across 3 companies, totaling $182.8K in disclosed volume. Weighing $54.7K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $37.0K in Serina Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Sep 2 | ELTX Elicio Therapeutics, Inc. | WILSON KAREN J | Director | Award | $58.7K |
| Jun 22 | SER Serina Therapeutics, Inc. | WILSON KAREN J | Director | Award | $30.2K |
| Jun 15 | SER Serina Therapeutics, Inc. | WILSON KAREN J | Director | Buy | $17.7K |
| May 26 | SER Serina Therapeutics, Inc. | WILSON KAREN J | Director | Buy | $37.0K |
| Mar 16 | CNTB Connect Biopharma Holdings Ltd | WILSON KAREN J | Director | Other | $0 |
| Nov 10 | SER Serina Therapeutics, Inc. | WILSON KAREN J | Director | Award | $39.1K |
6 filings